Estradiol treatment and its interaction with the cholinergic system: Effects on cognitive function in healthy young women

Hormones and Behavior

Volumn 54, Issue 5, 2008, Pages 684-693

  Bartholomeusz, Cali F ^a,g   Wesnes, Keith A ^b   Kulkarni, Jayashri ^c   Vitetta, Luis ^d   Croft, Rodney J ^a   Nathan, Pradeep J ^e,f  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b Cognitive Drug Research Ltd ^*  (United Kingdom)

^c Australia   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cholinergic system; Cognition; Estradiol; Healthy young women; Muscarinic receptors; Scopolamine

Indexed keywords

ESTRADIOL; PLACEBO; SCOPOLAMINE;

ADULT; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG METABOLISM; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; LEARNING; MENSTRUAL CYCLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERBAL MEMORY; WORKING MEMORY;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ATTENTION; CHOLINERGIC AGENTS; CHOLINERGIC ANTAGONISTS; CHOLINERGIC FIBERS; COGNITION; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ESTRADIOL; FEMALE; HEALTH; HUMANS; NEURONAL PLASTICITY; PLACEBOS; SCOPOLAMINE; YOUNG ADULT;

EID: 54149094281     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2008.07.007     Document Type: Article

References (106)

1. Alhola P., Polo-Kantola P., Erkkola R., and Portin R. Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women. Neurology 67 (2006) 706-709
2. Almeida O.P., Lautenschlager N., Vasikaram S., Leedman P., and Flicker L. Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. Am. J. Geriatr. Psychiatry 13 (2005) 142-149
3. Almeida O.P., Lautenschlager N.T., Vasikaran S., Leedman P., Gelavis A., and Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol. Aging 27 (2006) 141-149
4. Andolsek K.M. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent. Acta. Obstet. Gynecol. Scand. Suppl. 156 (1992) 22-26
5. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57 (2001) 605-612
6. Benton A.L., and Hamsher K. Multilingual Aphasia Examination (1976), University of Iowa Press, Iowa City
7. Bond A., and Lader M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol. 47 (1974) 211-218
8. Cardoso C.C., Pereira R.T., Koyama C.A., Porto C.S., and Abdalla F.M. Effects of estrogen on muscarinic acetylcholine receptors in the rat hippocampus. Neuroendocrinology 80 (2004) 379-386
9. Cyr M., Calon F., Morissette M., and Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry. Neurosci. 27 (2002) 12-27
10. Daniel J.M., Hulst J.L., and Lee C.D. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience 132 (2005) 57-64
11. Das A., Dikshit M., Srivastava S.R., Srivastava U.K., and Nath C. Effect of ovariectomy and estrogen supplementation on brain acetylcholinesterase activity and passive-avoidance learning in rats. Can. J. Physiol. Pharmacol. 80 (2002) 907-914
12. Dohanich G.P., Fader A.J., and Javorsky D.J. Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats. Behav. Neurosci. 108 (1994) 988-992
13. Duka T., Tasker R., and McGowan J.F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology. (Berl) 149 (2000) 129-139
14. Dumas J., Hancur-Bucci C., Naylor M., Sites C., and Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology 31 (2006) 2065-2078
15. Dumas J., Hancur-Bucci C., Naylor M., Sites C., and Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 53 (2008) 159-169
16. Ebert U., and Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 28 (1998) 944-949
17. El-Bakri N.K., Adem A., Suliman I.A., Mulugeta E., Karlsson E., Lindgren J.U., et al. Estrogen and progesterone treatment: effects on muscarinic M(4) receptor subtype in the rat brain. Brain Res. 948 (2002) 131-137
18. Ellis J.R., Ellis K.A., Bartholomeusz C.F., Harrison B.J., Wesnes K.A., Erskine F.F., et al. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int. J. Neuropsychopharmacol. 9 (2006) 175-189
19. Epting L.K., and Overman W.H. Sex-sensitive tasks in men and women: a search for performance fluctuations across the menstrual cycle. Behav. Neurosci. 112 (1998) 1304-1317
20. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory study. JAMA 291 (2004) 2959-2968
21. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48 (1997) 649-684
22. Fader A.J., Hendricson A.W., and Dohanich G.P. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol. Learn. Mem. 69 (1998) 225-240
23. Fader A.J., Johnson P.E., and Dohanich G.P. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze. Pharmacol. Biochem. Behav. 62 (1999) 711-717
24. Fedor-Freybergh P. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta. Obstet. Gynecol. Scand. Suppl. 64 (1977) 1-91
25. Foster T.C., Sharrow K.M., Kumar A., and Masse J. Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol. Aging 24 (2003) 839-852
26. Frye C.A. Estrus-associated decrements in a water maze task are limited to acquisition. Physiol. Behav. 57 (1995) 5-14
27. Fugger H.N., Cunningham S.G., Rissman E.F., and Foster T.C. Sex differences in the activational effect of ERalpha on spatial learning. Horm. Behav. 34 (1998) 163-170
28. Galea L.A., Kavaliers M., Ossenkopp K.P., and Hampson E. Gonadal hormone levels and spatial learning performance in the Morris water maze in male and female meadow voles, Microtus pennsylvanicus. Horm. Behav. 29 (1995) 106-125
29. Galea L.A., Kavaliers M., and Ossenkopp K.P. Sexually dimorphic spatial learning in meadow voles Microtus pennsylvanicus and deer mice Peromyscus maniculatus. J. Exp. Biol. 199 (1996) 195-200
30. Galen Buckwalter J., Crooks V.C., Robins S.B., and Petitti D.B. Hormone use and cognitive performance in women of advanced age. J. Am. Geriatr. Soc. 52 (2004) 182-186
31. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
32. Gibbs R.B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151 (1998) 289-302
33. Gibbs R.B. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm. Behav. 36 (1999) 222-233
34. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101 (2000) 931-938
35. Gibbs R.B. Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women. Novartis. Found Symp. 230 (2000) 94-107 discussion 107-11
36. Gibbs R.B., Wu D., Hersh L.B., and Pfaff D.W. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129 (1994) 70-80
37. Gibbs R.B., Wu D., Hersh L.B., and Pfaff D.W. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129 (1994) 70-80
38. Gibbs R.B., Burke A.M., and Johnson D.A. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm. Behav. 34 (1998) 112-125
39. Golden C.J. Stroop Color and Word Test (1978), Stoelting Co, Wood Dale
40. Golub M.S., Germann S.L., and Hogrefe C.E. Endocrine disruption and cognitive function in adolescent female rhesus monkeys. Neurotoxicol. Teratol. 26 (2004) 799-809
41. Gordon H.W., and Lee P.A. No difference in cognitive performance between phases of the menstrual cycle. Psychoneuroendocrinology 18 (1993) 521-531
42. Green A., Ellis K.A., Ellis J., Bartholomeusz C.F., Ilic S., Croft R.J., et al. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacol. Biochem. Behav. 81 (2005) 575-584
43. Halbreich U., and Kahn L.S. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28 Suppl. 2 (2003) 1-16
44. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology 15 (1990) 97-111
45. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn. 14 (1990) 26-43
46. Hampson E., and Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav. Neurosci. 102 (1988) 456-459
47. Herlitz A., Thilers P., and Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 14 (2007) 425-431
48. Hogervorst E., Williams J., Budge M., Riedel W., and Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101 (2000) 485-512
49. Hutchison C.W., Nathan P.J., Mrazek L., and Stough C. Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time. Psychopharmacology 155 4 (2001) 440-442
50. Janowsky J.S., Chavez B., and Orwoll E. Sex steroids modify working memory. J. Cogn. Neurosci. 12 (2000) 407-414
51. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13 (2006) 411-422
52. Kasamatsu K., Suzuki S., Anse M., Funada M.F., Idogawa K., and Ninomija S.P. Menstrual cycle effects on performance of mental arithmetic task. J. Physiol. Anthropol. Appl. Human Sci. 21 (2002) 285-290
53. Keenan P.A., Stern R.A., Janowsky D.S., and Pedersen C.A. Psychological aspects of premenstrual syndrome. I: Cognition and memory. Psychoneuroendocrinology 17 (1992) 179-187
54. Krug R., Born J., and Rasch B. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology 31 (2006) 965-975
55. Kulkarni J., Riedel A., de Castella A.R., Fitzgerald P.B., Rolfe T.J., Taffe J., et al. Estrogen - a potential treatment for schizophrenia. Schizophr. Res. 48 (2001) 137-144
56. Lethaby A., Hogervorst E., Richards M., Yesufu A., and Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. 23 (2008) CD003122
57. In: Leonard R. (Ed). Bayside Health Pathology Handbook (2004), Alfred Pathology Service, Melbourne
58. Lezak M.D., Howieson D.B., and Loring D.W. Neuropychological Assessment (2004), Oxford University Press, New York
59. Little J.T., Johnson D.N., Minichiello M., Weingartner H., and Sunderland T. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses. Neuropsychopharmacology 19 (1998) 60-69
60. Low L.F., Anstey K.J., Jorm A.F., Christensen H., and Rodgers B. Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years. Maturitas 54 (2006) 86-94
61. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89 (1985) 484-490
62. MacLeod C.M. Half a century of research on the Stroop effect: an integrative review. Psychol. Bull. 109 (1991) 163-203
63. Maki P.M., Zonderman A.B., and Resnick S.M. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am. J. Psychiatry 158 (2001) 227-233
64. Maki P.M., Rich J.B., and Rosenbaum R.S. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 40 (2002) 518-529
65. Marriott L.K., Hauss-Wegrzyniak B., Benton R.S., Vraniak P.D., and Wenk G.L. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behav. Neurosci. 116 (2002) 902-911
66. McClelland G.R. The effects of practice on measures of performance. Human Psychopharm. 2 (1987) 109-118
67. McMillan P.J., Singer C.A., and Dorsa D.M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 16 (1996) 1860-1865
68. Mercuro G., Balloi C., De Candia G., Panzuto M.G., Zoncu S., Cagnacci A., et al. Effects of transdermal estrogen administration on peripheral vascular responsiveness in menopausal women. Int. J. Angiol. 6 (1997) 237-240
69. Norbury R., Travis M.J., Erlandsson K., Waddington W., Ell P.J., and Murphy D.G. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study. Horm. Behav. 51 (2007) 249-257
70. Osterlund M.K., and Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 64 (2001) 251-267
71. Phillips S.M., and Sherwin B.B. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17 (1992) 497-506
72. Portin R., Polo-Kantola P., Polo O., Koskinen T., Revonsuo A., Irjala K., et al. Serum estrogen level, attention, memory and other cognitive functions in middle-aged women. Climacteric 2 (1999) 115-123
73. Reisman H., Martin D., and Gast M.J. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. Am. J. Obstet. Gynecol. 181 (1999) 45-52
74. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 91 (2006) 1802-1810
75. Rey A. L'examen Clinique en Psychologie (1964), Presses Universitaries de France, Paris
76. Robbins T.W., Semple J., Kumar R., Truman M.I., Shorter J., Ferraro A., et al. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology (Berl). 134 (1997) 95-106
77. Rosenberg L., and Park S. Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 27 (2002) 835-841
78. Safer D.J., and Allen R.P. The central effects of scopolamine in man. Biol. Psychiatry 3 (1971) 347-355
79. Sarter M., Hasselmo M.E., Bruno J.P., and Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res. Brain Res. Rev. 48 (2005) 98-111
80. Savonenko A.V., and Markowska A.L. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 119 (2003) 821-830
81. Schiff R., Bulpitt C.J., Wesnes K.A., and Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology 30 (2005) 309-315
82. Schmidt M. Rey Auditory and Verbal Learning Test: a Handbook (1996), Western Psychological Services, Los Angeles
83. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., and Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 121 Pt 12 (1998) 2249-2257
84. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr. Rev. 24 (2003) 133-151
85. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 138 (2006) 1021-1026
86. Sherwin B.B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J. Neuroendocrinol. 19 (2007) 77-81
87. Simpson E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86 (2003) 225-230
88. Singh M., Meyer E.M., Millard W.J., and Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644 (1994) 305-312
89. Smith Y.R., Minoshima S., Kuhl D.E., and Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 86 (2001) 679-684
90. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 18 (1935) 643-661
91. Symonds C.S., Gallagher P., Thompson J.M., and Young A.H. Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women. Psychol. Med. 34 (2004) 93-102
92. Tabachnick B.G., and Fidell L.S. Computer Assisted Research Design and Analysis (2001), Allyn and Bacon, Boston
93. Tanabe F., Miyasaka N., Kubota T., and Aso T. Estrogen and progesterone improve scopolamine-induced impairment of spatial memory. J. Med. Dent. Sci. 51 (2004) 89-98
94. Taylor E.M. Psychological Appraisal of Children with Cerebral Defects (1959), Harvard University Press, Cambridge
95. Thompson J.C., Stough C., Ames D., Ritchie C., and Nathan P.J. Effects of the nicotinic antagonist mecamylamine on inspection time. Psychopharmacology 150 1 (2000) 117-119
96. Tinkler G.P., and Voytko M.L. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 423-431
97. Tinkler G.P., Tobin J.R., and Voytko M.L. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J. Comp. Neurol. 469 (2004) 507-521
98. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4668-4672
99. Ussher J.M., and Wilding J.M. Performance and state changes during the menstrual cycle, conceptualised within a broad band testing framework. Soc. Sci. Med. 32 (1991) 525-534
100. Vaucher E., Reymond I., Najaffe R., Kar S., Quirion R., Miller M.M., et al. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol. Aging 23 (2002) 87-95
101. Wesnes K., and Pincock C. Practice effects on cognitive tasks: a major problem?. Lancet. Neurol. 1 (2002) 473
102. Wisniewski A.B., Nguyen T.T., and Dobs A.S. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm. Res. 58 (2002) 150-155
103. Yaffe K., Grady D., Pressman A., and Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J. Am. Geriatr. Soc. 46 (1998) 816-821
104. Yaffe K., Vittinghoff E., Ensrud K.E., Johnson K.C., Diem S., Hanes V., et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch. Neurol. 63 (2006) 945-950
105. Yonker J.E., Eriksson E., Nilsson L.G., and Herlitz A. Sex differences in episodic memory: minimal influence of estradiol. Brain Cogn. 52 (2003) 231-238
106. Zec R.F., and Trivedi M.A. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol. Rev. 12 (2002) 65-109